These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 38126608)

  • 1. Tau and Alzheimer's disease: Past, present and future.
    Iqbal K
    Cytoskeleton (Hoboken); 2024 Jan; 81(1):116-121. PubMed ID: 38126608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinases and phosphatases and tau sites involved in Alzheimer neurofibrillary degeneration.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Eur J Neurosci; 2007 Jan; 25(1):59-68. PubMed ID: 17241267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms of tau-induced neurodegeneration.
    Iqbal K; Liu F; Gong CX; Alonso Adel C; Grundke-Iqbal I
    Acta Neuropathol; 2009 Jul; 118(1):53-69. PubMed ID: 19184068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of neurofibrillary degeneration and the formation of neurofibrillary tangles.
    Iqbal K; Alonso AC; Gong CX; Khatoon S; Pei JJ; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 1998; 53():169-80. PubMed ID: 9700655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. AMPK is abnormally activated in tangle- and pre-tangle-bearing neurons in Alzheimer's disease and other tauopathies.
    Vingtdeux V; Davies P; Dickson DW; Marambaud P
    Acta Neuropathol; 2011 Mar; 121(3):337-49. PubMed ID: 20957377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitination and abnormal phosphorylation of paired helical filaments in Alzheimer's disease.
    Iqbal K; Grundke-Iqbal I
    Mol Neurobiol; 1991; 5(2-4):399-410. PubMed ID: 1726645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tau in Alzheimer disease and related tauopathies.
    Iqbal K; Liu F; Gong CX; Grundke-Iqbal I
    Curr Alzheimer Res; 2010 Dec; 7(8):656-64. PubMed ID: 20678074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors.
    Brunden KR; Ballatore C; Crowe A; Smith AB; Lee VM; Trojanowski JQ
    Exp Neurol; 2010 Jun; 223(2):304-10. PubMed ID: 19744482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of tau self-aggregation and neurotoxicity.
    Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB
    Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tau, tau kinases, and tauopathies: An updated overview.
    Montalto G; Ricciarelli R
    Biofactors; 2023; 49(3):502-511. PubMed ID: 36688478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycosylation of microtubule-associated protein tau: an abnormal posttranslational modification in Alzheimer's disease.
    Wang JZ; Grundke-Iqbal I; Iqbal K
    Nat Med; 1996 Aug; 2(8):871-5. PubMed ID: 8705855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance and mechanism of Alzheimer neurofibrillary degeneration and therapeutic targets to inhibit this lesion.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tsujio I; Wang JZ; Grundke-Iqbal I
    J Mol Neurosci; 2002; 19(1-2):95-9. PubMed ID: 12212801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of neurofibrillary degeneration and pharmacologic therapeutic approach.
    Iqbal K; Alonso AD; Gondal JA; Gong CX; Haque N; Khatoon S; Sengupta A; Wang JZ; Grundke-Iqbal I
    J Neural Transm Suppl; 2000; 59():213-22. PubMed ID: 10961432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alzheimer neurofibrillary degeneration: therapeutic targets and high-throughput assays.
    Iqbal K; Alonso Adel C; El-Akkad E; Gong CX; Haque N; Khatoon S; Pei JJ; Tanimukai H; Tsujio I; Wang JZ; Grundke-Iqba I
    J Mol Neurosci; 2003; 20(3):425-9. PubMed ID: 14501027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of neurofibrillary degeneration: a promising approach to Alzheimer's disease and other tauopathies.
    Iqbal K; Grundke-Iqbal I
    Curr Drug Targets; 2004 Aug; 5(6):495-502. PubMed ID: 15270196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphorylated Tau in Alzheimer's Disease and Other Tauopathies.
    Rawat P; Sehar U; Bisht J; Selman A; Culberson J; Reddy PH
    Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361631
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau pathology in Alzheimer disease and other tauopathies.
    Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I
    Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Trends Neurosci; 1993 Nov; 16(11):460-5. PubMed ID: 7507619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tau as a therapeutic target for Alzheimer's disease.
    Boutajangout A; Sigurdsson EM; Krishnamurthy PK
    Curr Alzheimer Res; 2011 Sep; 8(6):666-77. PubMed ID: 21679154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tau protein and the neurofibrillary pathology of Alzheimer's disease.
    Goedert M
    Ann N Y Acad Sci; 1996 Jan; 777():121-31. PubMed ID: 8624074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.